# Isoleucine Addition Treatment Effects in a Controlled Diet Study

> **NCT07329088** · NA · WITHDRAWN · sponsor: **Jean L. Fry**

## Conditions studied

- Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
- Metabolic Syndrome (MetS)
- Obesity & Overweight

## Interventions

- **DIETARY_SUPPLEMENT:** L-Isoleucine
- **OTHER:** Low-isoleucine diet

## Key facts

- **NCT ID:** NCT07329088
- **Lead sponsor:** Jean L. Fry
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-05-04
- **Primary completion:** 2029-01-31
- **Final completion:** 2029-01-31
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was not funded.
- **Last updated:** 2026-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07329088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07329088, "Isoleucine Addition Treatment Effects in a Controlled Diet Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07329088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*